ACTN4 and cancer: Since ACTN4/Akt-induced EMT may cause the resistance of cancer cells to DNA-damaging drugs [81,82], it is tempting to speculate that this mechanism is responsible for the failure of genotoxic anti-cancer therapies (Table 1).